Tesamorelin

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to stimulate endogenous growth hormone secretion and subsequently increase IGF-1 levels. It has been studied extensively in metabolic and endocrine research, and in the United States it is FDA-approved for a specific indication involving abdominal fat accumulation in certain patient populations. Beyond this regulated use, Tesamorelin continues to be investigated for its potential influence on insulin sensitivity, liver metabolism, body composition, and broader metabolic pathways. Scientific studies have also explored Tesamorelin’s relationship to cognitive function, particularly in aging populations and in research examining mild cognitive impairment and Alzheimer’s-related risk…